Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation

Molecular Cancer Therapeutics

Volumn 11, Issue 6, 2012, Pages 1269-1278

  Katt, William P ^a   Ramachandran, Sekar ^a   Erickson, Jon W ^a   Cerione, Richard A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (3 BROMO 4 (DIMETHYLAMINO)PHENYL) 2,2 DIMETHYL 2,3,5,6 TETRAHYDROBENZO[A]PHENANTHRIDIN 4(1H) ONE; 968; GLUTAMINASE C; MITOCHONDRIAL ENZYME; PHENANTHRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BINDING SITE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MUTAGENESIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOPHENANTHRIDINES; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLUTAMINASE; HUMANS; MICE; MODELS, MOLECULAR; PHENANTHRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84862567758     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-11-0942     Document Type: Article

References (34)

1. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
2. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
3. Mates JM, Segura JA, Campos-Sandoval JA, Lobo C, Alonso L, Alonso FJ, et al. Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol 2009;41:2051-61.
4. Gogvadze V, Zhivotovsky B, Orrenius S. The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 2010;31:60-74.
5. Mathupala SP, Ko YH, Pedersen PL. The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta 2010;1797:1225-30.
6. Annibaldi A, Widmann C. Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care 2010;13:466-70.
7. Kaelin WG Jr, Thompson CB. Q&A: Cancer: clues from cell metabolism. Nature 2010;465:562-4.
8. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010;10:267-77.
9. Kenny J, Bao Y, Hamm B, Taylor L, Toth A, Wagers B, et al. Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase. Protein Expr Purif 2003;31:140-8. (Pubitemid 37207652)
10. Brosnan JT, Ewart HS, Squires SA. Hormonal control of hepatic glutaminase. Adv Enzyme Regul 1995;35:131-46.
11. Szeliga M, Obara-Michlewska M. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases. Neurochem Int 2009;55:71-5.
12. Gomez-Fabre PM, Aledo JC, Del Castillo-Olivares A, Alonso FJ, Nunez De Castro I, Campos JA, et al. Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem J 2000;345:365-75.
13. Aledo JC, Gomez-Fabre PM, Olalla L, Marquez J. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm Genome 2000;11:1107-10.
14. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1999;1:51-62. (Pubitemid 129622451)
15. Roberg B, Torgner IA, Kvamme E. The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondria. Neurochem Int 1995;27:367-76.
16. Shapiro RA, Haser WG, Curthoys NP. The orientation of phosphatedependent glutaminase on the inner membrane of rat renal mitochondria. Arch Biochem Biophys 1985;243:1-7. (Pubitemid 16198702)
17. Aledo JC, de Pedro E, Gomez-Fabre PM, Nunez de Castro I, Marquez J. Submitochondrial localization and membrane topography of Ehrlich ascitic tumour cell glutaminase. Biochim Biophys Acta 1997;1323:173-84. (Pubitemid 27065366)
18. Kalra J, Brosnan JT. The subcellular localization of glutaminase isoenzymes in rat kidney cortex. J Biol Chem 1974;249:3255-60.
19. Szeliga M, Matyja E, Obara M, Grajkowska W, Czernicki T, Albrecht J. Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem Res 2008;33:808-13. (Pubitemid 351423146)
20. Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010;18:207-19.
21. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 2000;19:1123-31. (Pubitemid 30157541)
22. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr. Constitutive activation of NF-kappaB during progression of breast cancer tohormone-independent growth.Mol Cell Biol1997;17:3629-39. (Pubitemid 27281838)
23. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997;100:2952-60. (Pubitemid 28022831)
24. Kvamme E, Torgner IA, Roberg B. Kinetics and localization of brain phosphate activated glutaminase. J Neurosci Res 2001;66:951-8.
25. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995;15:133-59.
26. Godfrey S, Kuhlenschmidt T, Curthoys NP. Correlation between activation and dimer formation of rat renal phosphate-dependent glutaminase. J Biol Chem 1977;252:1927-31. (Pubitemid 8077579)
27. Morehouse RF, Curthoys NP. Properties of rat renal phosphatedependent glutaminase coupled to Sepharose. Evidence that dimerization is essential for activation. Biochem J 1981;193:709-16.
28. Kvamme E, Torgner IA. Phosphate-dependent effects of palmityl-CoA and stearyl-CoA on phosphate-activated pig brain and pig kidney glutaminase. FEBS Lett 1974;47:244-7.
29. Kvamme E, Torgner IA. The effect of acetyl-coenzyme A on phosphate-activated glutaminase from pig kidney and brain. Biochem J 1974;137:525-30.
30. Willis RC, Seegmiller JE. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast. J Cell Physiol 1977;93:375-82. (Pubitemid 8226660)
31. Curthoys NP, Lowry OH. The distribution of glutaminase isoenzymes in the various structures of the nephron in normal, acidotic, and alkalotic rat kidneys. J Biol Chem 1973;248:162-8.
32. Yoshimune K, Shirakihara Y, Wakayama M, Yumoto I. Crystal structure of salt-tolerant glutaminase from Micrococcus luteus K-3 in the presence and absence of its product L-glutamate and its activator Tris. FEBS J 2010;277:738-48.
33. DeLaBarre B, Gross S, Fang C, Gao Y, Jha A, Jiang F, et al. Full-length human glutaminase in complex with an allosteric inhibitor. Biochemistry 2011;50:10764-70.
34. Hartwick EW, Curthoys NP. BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase. J Enzyme Inhib Med Chem. 2011 Oct 15. [Epub ahead of print].